✦ LIBER ✦

Selegiline helps stabilise levodopa dosages in Parkinson’s disease

Book ID: 120877695
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1997
Weight: 258 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199710840-00022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experience with selegiline and levodopa

Experience with selegiline and levodopa in advanced Parkinson's disease

✍ A. Lieberman; E. Fazzini 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB

Early selegiline therapy reduces levodop

Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease

✍ V. V. Myllylä; E. H. Heinonen; J. A. Vuorinen; O.I. Kilkku; K. A. Sotaniemi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Levodopa, bromocriptine and selegiline m

Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease

✍ Tarja H. Haapaniemi; Mika A. Kallio; Juha T. Korpelainen; Kalervo Suominen; Uole 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 232 KB

Selegiline in Parkinson's disease

✍ H. Teräväinen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

Levodopa in Parkinson’s Disease

✍ Dr M. Gustavo Murer, Rita Raisman-Vozari, Oscar Gershanik 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 181 KB

Selegiline and mortality in Parkinson's

Selegiline and mortality in Parkinson's disease

✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran